Vivimed Labs has signed definitive agreements to facilitate an investment of $42.5 million by OrbiMed Asia into the Company’s subsidiary, Vivimed Labs Mascarene, the holding entity of the company’s API business, UQUIFA.
The proceeds of this fund raise will be utilized by the company primarily for Debt reduction and optimization of capital structure at the parent entity level and investment in the API business for capacity augmentation and organic growth.
Vivimed Labs is engaged in providing specialty chemicals and pharmaceuticals products. The company offers products for oral care, sun care, skin care, hair care, reversacol photochromic dyes, imaging chemicals and nisarg.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1677.90 |
| Dr. Reddys Lab | 1230.00 |
| Cipla | 1229.00 |
| Zydus Lifesciences | 932.15 |
| Lupin | 2333.50 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: